Tianjin Chase Sun Pharmaceutical Co Ltd Cash Flow Quality Index
Tianjin Chase Sun Pharmaceutical Co Ltd cash flow quality index. Tianjin Chase Sun Pharmaceutical Co Ltd (300026) has a Cash Flow Quality Index of 71.88x as of September 2025. Operating cash flow of CN¥153.30 Million exceeds net income of CN¥2.13 Million, indicating high earnings quality where cash backs reported profits. See 300026 financial flexibility score to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Tianjin Chase Sun Pharmaceutical Co Ltd (2006–2024)
Cash flow quality index of Tianjin Chase Sun Pharmaceutical Co Ltd from 2006 to 2024. Historical Cash Flow Quality Index for Tianjin Chase Sun Pharmaceutical Co Ltd across 19 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Tianjin Chase Sun Pharmaceutical Co Ltd cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Tianjin Chase Sun Pharmaceutical Co Ltd Cash Flow Quality Index by Year (2006–2024)
Tianjin Chase Sun Pharmaceutical Co Ltd cash flow quality index by year from 2006 to 2024. Year-by-year earnings quality comparison for Tianjin Chase Sun Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see Tianjin Chase Sun Pharmaceutical Co Ltd operating cash flow efficiency.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 37.14x | CN¥852.24 Million | CN¥22.95 Million | ▲ +1117.5% |
| 2023 | 3.05x | CN¥1.53 Billion | CN¥501.57 Million | ▲ +154.2% |
| 2022 | 1.20x | CN¥745.35 Million | CN¥620.97 Million | ▲ +105.6% |
| 2021 | 0.58x | CN¥391.60 Million | CN¥670.85 Million | ▲ +66.1% |
| 2020 | 0.35x | CN¥196.66 Million | CN¥559.68 Million | ▼ -33.6% |
| 2019 | 0.53x | CN¥216.10 Million | CN¥408.43 Million | ▼ -70.6% |
| 2018 | 1.80x | CN¥388.19 Million | CN¥215.91 Million | ▲ +8.3% |
| 2017 | 1.66x | CN¥742.38 Million | CN¥447.21 Million | ▲ +144.9% |
| 2016 | 0.68x | CN¥448.08 Million | CN¥661.08 Million | ▲ +200.4% |
| 2015 | 0.23x | CN¥121.00 Million | CN¥536.23 Million | ▼ -32.4% |
| 2014 | 0.33x | CN¥149.94 Million | CN¥448.94 Million | ▼ -20.7% |
| 2013 | 0.42x | CN¥143.60 Million | CN¥340.90 Million | ▼ -27.9% |
| 2012 | 0.58x | CN¥152.21 Million | CN¥260.68 Million | ▲ +147.2% |
| 2011 | 0.24x | CN¥35.64 Million | CN¥150.91 Million | ▼ -42.1% |
| 2010 | 0.41x | CN¥46.25 Million | CN¥113.35 Million | ▼ -75.5% |
| 2009 | 1.67x | CN¥135.06 Million | CN¥80.97 Million | ▲ +38.2% |
| 2008 | 1.21x | CN¥77.74 Million | CN¥64.39 Million | ▼ -34.4% |
| 2007 | 1.84x | CN¥72.01 Million | CN¥39.16 Million | ▲ +1005.9% |
| 2006 | 0.17x | CN¥1.22 Million | CN¥7.36 Million | — |